(Q35123237)

6 August 2017

1 reference

title

Contemporary pathology of prostate cancer (English)

1 reference

6 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

31 December 2023

1

David G Bostwick

1 reference

6 August 2017

Junqi Qian

2

1 reference

6 August 2017

Cory Schlesinger

3

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12735497

31 December 2023

publication date

1 May 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S0094014302001891?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

https://api.elsevier.com/content/article/PII:S0094014302001891?httpAccept=text/plain

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

Urologic Clinics of North America

31 December 2023

published in

1 reference

6 August 2017

volume

30

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

181-207

1 reference

Adequate tissue sampling of prostate core needle biopsies

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Diagnostic effect of complete histologic sampling of prostate needle biopsy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

How often are diagnostic features missed with less extensive histologic sampling of prostate needle biopsy specimens?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Needle core length in sextant biopsy influences prostate cancer detection rate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Interobserver Reproducibility in the Diagnosis of Prostatic Intraepithelial Neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Origins of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

High grade prostatic intraepithelial neoplasia is a disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Intraductal dysplasia: a premalignant lesion of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Prostatic intra-epithelial neoplasia and early invasion in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Precursor lesions for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Is prostatic intraepithelial neoplasia in the transition/central zone a true precursor of cancer? A long-term retrospective study in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Prostatic intraepithelial neoplasia in surgical resections: relationship to coexistent adenocarcinoma and atypical adenomatous hyperplasia of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Follow-up of prostatic intraepithelial neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Incidence and clinical significance of high-grade prostatic intraepithelial neoplasia in TURP specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Prevalence and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Latent carcinoma and atypical lesions of prostate. An autopsy study.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Architectural patterns of high-grade prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Unusual histologic types of high-grade prostatic intraepithelial neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Foamy gland high-grade prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Molecular biology of prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

High grade prostatic intraepithelial neoplasia in military working dogs with and without prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Prostatic intraepithelial neoplasia: animal models 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

The significance of prostatic intra-epithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Effect of neoadjuvant hormonal therapy on prostatic intraepithelial neoplasia and its prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Pathologic changes associated with androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Does age influence the behaviour of localized prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Staging and reporting of prostate cancer--sampling of the radical prostatectomy specimen

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

An Abbreviated Standard Procedure for Accurate Tumor Volume Estimation in Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Characterization of localized prostatic cancer: distribution, grading and pT-staging in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Staging of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Sampling of radical prostatectomy specimens. How much is adequate?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Observations on the number, size and localization of nucleoli in hyperplastic and neoplastic prostatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Signet ring cell differentiation in adenocarcinoma of the prostate: a study of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Use of prostate-specific antigen and tumor volume in predicting needle biopsy grading error

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Effect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Heterogeneity of prostate cancer in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Primary Gleason pattern as a predictor of disease progression in gleason score 7 prostate cancer: a multivariate analysis of 823 men treated with radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Sulfur-rich prostatic intraluminal crystalloids: a surgical pathologic and electron probe x-ray microanalytic study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Crystalloids in metastatic prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Intraluminal crystalloids in metastatic prostatic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3,N+) versus lymph node-negative (pT2-3,N0) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Perineural invasion on prostate needle biopsy: an independent predictor of final pathologic stage

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

The presence of benign prostatic glands in perineural spaces.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Correlation of perineural invasion on radical prostatectomy specimens with other pathologic prognostic factors and PSA failure

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

The relationship between early biochemical failure and perineural invasion in pathological T2 prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Incidence and prognostic significance of lymphatic and vascular invasion in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

The TNM classification of prostate cancer: a discussion of the 1992 classification. The British Association of Urological Surgeons TNM Subcommittee

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

The 1995 staging requirement for approved cancer programs

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Prognostic significance of capsular invasion and capsular penetration in patients with clinically localized prostate cancer undergoing radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Correlation of margin status and extraprostatic extension with progression of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Prognostic significance of positive surgical margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Radical prostatectomy. Patterns of local failure and survival in 67 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Extranodal extension in lymph node-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Pathologic classification of prostate carcinoma: the impact of margin status

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Positive surgical margins at radical prostatectomy: importance of the apical dissection.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Resection margin status in radical retropubic prostatectomy specimens: relationship to type of operation, tumor size, tumor grade and local tumor extension

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Nerve-sparing radical prostatectomy: extraprostatic tumor extension and preservation of erectile function

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Impact of Radical Prostatectomy in the Management of Clinically Localized Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Standardized in vitro mapping with multiple core biopsies of total prostatectomy specimens: localization and prediction of tumour volume and grade

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Identification of insignificant prostate cancers: analysis of preoperative parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Computer simulation of the probability of detecting low volume carcinoma of the prostate with six random systematic core biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Single focus of adenocarcinoma in the prostate biopsy specimen is not predictive of the pathologic stage of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Is the percentage of cancer in biopsy cores predictive of extracapsular disease in T1-T2 prostate carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Do the results of systematic biopsies predict outcome in patients with T1-T2 prostate cancer treated with radiation therapy alone?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Pathologic findings and prostate specific antigen outcome after radical prostatectomy for patients diagnosed on the basis of a single microscopic focus of prostate carcinoma with a gleason score </= 7

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Biological determinants of cancer progression in men with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Tumor volume and prostate specific antigen: implications for early detection and defining a window of curability

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

The definition and preoperative prediction of clinically insignificant prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Tissue-shrinkage correction factor in the calculation of prostate cancer volume

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Minimal or no cancer in radical prostatectomy specimens. Report of 13 cases of the "vanishing cancer phenomenon".

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Increasing incidence of minimal residual cancer in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Does prostatic ductal adenocarcinoma exist?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Mucinous adenocarcinoma of the prostate: Histochemical and immunohistochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Mucinous differentiation in prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Unusual primary prostatic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Mucinous adenocarcinoma of the prostate and hormone sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Mucins in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Mucinous metaplasia in the prostate gland.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Prostatic adenocarcinoma with glomeruloid features

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Pseudohyperplastic prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Pseudohyperplastic prostatic adenocarcinoma on needle biopsy and simple prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Adenocarcinoma of the prostate with atrophic features.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Prostatic adenocarcinoma with atrophic features: a study of 202 consecutive completely embedded radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Primary squamous cell carcinoma of the prostate after radiation seed implantation for adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Adenosquamous carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Clinical and Pathobiological Effects of Neoadjuvant Total Androgen Ablation Therapy on Clinically Localized Prostatic Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Histologic changes in prostate carcinomas treated with leuprolide (luteinizing hormone-releasing hormone effect). Distinction from poor tumor differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Effect of combination endocrine therapy (LHRH agonist and flutamide) on normal prostate and prostatic adenocarcinoma. A histopathologic and immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Pathological changes in prostate lesions after androgen manipulation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Assessment of prostate carcinoma in core needle biopsy--definition of minimal criteria for the diagnosis of cancer in biopsy material

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Radiation injury of the normal and neoplastic prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Histological and immunohistochemical findings of prostatic carcinoma after external or interstitial radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Histologic changes of irradiated prostatic carcinoma diagnosed by transrectal ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Dedifferentiation of locally recurrent prostate cancer after radiation therapy. Evidence for tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Diagnosis of prostate cancer in needle biopsies after radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Management of radiation failure for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

p53 immunohistochemical and genetic alterations are associated at high incidence with post-irradiated locally persistent prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

The histology of radiation therapy effect on prostate adenocarcinoma as assessed by needle biopsy after brachytherapy boost. Correlation with biochemical failure

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Effects of radiation on the normal prostate gland

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900189-1

7 January 2021

Atypical adenomatous hyperplasia of the prostate: a premalignant lesion?

9

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

Unsuspected Prostate Carcinoma and Prostatic Intraepithelial Neoplasm in Taiwanese Patients Undergoing Cystoprostatectomy

31 December 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer

31 December 2023

44

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

DNA distribution in the prostate. Normal gland, benign and premalignant lesions, and subsequent adenocarcinomas

31 December 2023

52

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

Recommendations for the reporting of resected prostate carcinomas. Association of Directors of Anatomical and Surgical Pathology

31 December 2023

67

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

Signet-ring cell carcinoma of the prostate

31 December 2023

83

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

Gleason histologic grading in prostatic carcinoma. Correlation of 18-gauge core biopsy with prostatectomy

31 December 2023

89

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

Collagenous micronodules in prostate cancer. A specific but infrequent diagnostic finding

31 December 2023

100

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy

31 December 2023

105

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

Microvascular invasion in prostate cancer correlates with pathologic stage

31 December 2023

114

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

The TNM classification of prostate cancer

31 December 2023

115

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

Digital Rectal Examination, Imaging, and Systematic- Sextant Biopsy in Identifying Operable Lymph Node-Negative Prostatic Carcinoma

31 December 2023

143

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

Pathologic Handling and Reporting of Prostate Tissue Specimens in Patients Receiving Neoadjuvant Hormonal Therapy: Report of the Pathology Committee

31 December 2023

196

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

Immunohistochemical Analysis of Radical Prostatectomy Specimens After 8 Months of Neoadjuvant Hormonal Therapy

31 December 2023

198

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy

31 December 2023

208

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00189-1

31 December 2023

Identifiers

1 reference

6 August 2017

1 reference